Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553 |
filingDate |
1986-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1988-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76736063d1578c38e1e0bd7537ea3974 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e57b9c2413ef8e9afa6fcb51c4ea9ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_442a732b4ebd2f3b26f5216ece5ad8f5 |
publicationDate |
1988-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-4719213-A |
titleOfInvention |
Anti-cancer composition for delivering 5-fluorouracil |
abstract |
An anti-cancer composition for delivering a 5-fluorouracil to cancer tissues in a warm-blooded animal, wherein the cancer is a cancer sensitive to 5-fluorouracil. The composition comprises uracil or a pharmaceutically acceptable salt thereof, and a 5-fluorouracil pro drug selected from the group consisting of 1, 3-bis (2-tetrahydrofuryl)-5-fluorouracil and 3-(2-tetrahydrofuryl)-5-fluorouracil in a small amount of about 0.1 to less than 0.1 mole per mole of uracil or salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011262561-A1 |
priorityDate |
1977-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |